BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17380466)

  • 1. [Impairments of action control in the context of neuropsychological findings in schizophrenia].
    Reuter B; Kathmann N
    Fortschr Neurol Psychiatr; 2007 Oct; 75(10):607-16. PubMed ID: 17380466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antisaccade task as a research tool in psychopathology: a critical review.
    Hutton SB; Ettinger U
    Psychophysiology; 2006 May; 43(3):302-13. PubMed ID: 16805870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor antisaccade performance in schizophrenia: an inhibition deficit?
    Reuter B; Rakusan L; Kathmanna N
    Psychiatry Res; 2005 May; 135(1):1-10. PubMed ID: 15893384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurocognitive changes and negative symptoms in schizophrenia].
    Thoma P; Daum I
    Fortschr Neurol Psychiatr; 2005 Jun; 73(6):333-42. PubMed ID: 15942863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task.
    Karch S; Leicht G; Giegling I; Lutz J; Kunz J; Buselmeier M; Hey P; Spörl A; Jäger L; Meindl T; Pogarell O; Möller HJ; Hegerl U; Rujescu D; Mulert C
    J Psychiatr Res; 2009 Oct; 43(15):1185-94. PubMed ID: 19426993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperfrontality in patients with schizophrenia during saccade and antisaccade tasks: a study with fMRI.
    Fukumoto-Motoshita M; Matsuura M; Ohkubo T; Ohkubo H; Kanaka N; Matsushima E; Taira M; Kojima T; Matsuda T
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):209-17. PubMed ID: 19335390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings.
    Reichenberg A; Harvey PD
    Psychol Bull; 2007 Sep; 133(5):833-58. PubMed ID: 17723032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine reduces antisaccade errors in task impaired schizophrenic subjects.
    Larrison-Faucher AL; Matorin AA; Sereno AB
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):505-16. PubMed ID: 15093958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced error-related activation in two anterior cingulate circuits is related to impaired performance in schizophrenia.
    Polli FE; Barton JJ; Thakkar KN; Greve DN; Goff DC; Rauch SL; Manoach DS
    Brain; 2008 Apr; 131(Pt 4):971-86. PubMed ID: 18158315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using saccade tasks as a tool to analyze executive dysfunctions in schizophrenia.
    Reuter B; Kathmann N
    Acta Psychol (Amst); 2004; 115(2-3):255-69. PubMed ID: 14962403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saccade generation and suppression in schizophrenia: effects of response switching and perseveration.
    Franke C; Arndt D; Ploner CJ; Heinz A; Reuter B
    Psychophysiology; 2008 Sep; 45(5):698-704. PubMed ID: 18513361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological functioning and brain structure in schizophrenia.
    Crespo-Facorro B; Barbadillo L; Pelayo-Terán JM; Rodríguez-Sánchez JM
    Int Rev Psychiatry; 2007 Aug; 19(4):325-36. PubMed ID: 17671866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired action control in schizophrenia: the role of volitional saccade initiation.
    Reuter B; Jäger M; Bottlender R; Kathmann N
    Neuropsychologia; 2007 Apr; 45(8):1840-8. PubMed ID: 17258779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisaccade performance in patients with multiple sclerosis.
    Fielding J; Kilpatrick T; Millist L; White O
    Cortex; 2009; 45(7):900-3. PubMed ID: 19327763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Temporal perception and organisation, neuronal synchronisation and schizophrenia].
    Braus DF
    Fortschr Neurol Psychiatr; 2002 Nov; 70(11):591-600. PubMed ID: 12410429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognition and the inhibitory control of saccades in schizophrenia and Parkinson's disease.
    Crawford TJ; Bennett D; Lekwuwa G; Shaunak S; Deakin JF
    Prog Brain Res; 2002; 140():449-66. PubMed ID: 12508608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisaccade performance is related to genetic loading for schizophrenia.
    Petrovsky N; Weiss-Motz F; Schulze-Rauschenbach S; Lemke M; Hornung P; Ruhrmann S; Klosterkötter J; Maier W; Ettinger U; Wagner M
    J Psychiatr Res; 2009 Jan; 43(3):291-7. PubMed ID: 18585739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain potentials indicate poor preparation for action in schizophrenia.
    Reuter B; Herzog E; Endrass T; Kathmann N
    Psychophysiology; 2006 Nov; 43(6):604-11. PubMed ID: 17076817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do antisaccade deficits in schizophrenia provide evidence of a specific inhibitory function?
    Donohoe G; Reilly R; Clarke S; Meredith S; Green B; Morris D; Gill M; Corvin A; Garavan H; Robertson IH
    J Int Neuropsychol Soc; 2006 Nov; 12(6):901-6. PubMed ID: 17064452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease?
    van Stockum S; MacAskill M; Anderson T; Dalrymple-Alford J
    Neuropsychologia; 2008 Nov; 46(13):3108-15. PubMed ID: 18674551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.